Entopsis, founded in 2011 and headquartered in Hialeah, Florida, is dedicated to developing innovative biomedical products for research and clinical applications. The company focuses on oncology, autoimmune disorders, metabolic disorders, and malignancies prevalent in developing regions. Entopsis has created platforms such as OpsisDx and NuTec, which offer novel methods for biomolecule analysis and detection, potentially revolutionizing fields from food safety to medicine.
Entopsis has established numerous strategic collaborations with industry and academic partners to advance its mission. The company's achievements include the development of versatile platforms like NuTec, which has been praised for its unprecedented potential to transform detection methods. Notable endorsements include Linda Fishburne from Breakout Labs, highlighting the paradigm-shifting capabilities of Entopsis's technologies.
